PARK7-driven IGF2BP3-K76 lactylation mediates ferroptosis and HAIC resistance in hepatocellular carcinoma.

Summary: Liver cancer is very hard to treat. Doctors often use a powerful treatment called HAIC, which delivers strong cancer-fighting drugs straight into the liver. It works well at first, but over time, the cancer often learns how to survive the drugs.

Scientists recently discovered exactly how the cancer protects itself. A protein in the body called PARK7 helps change the shape of another protein (IGF2BP3) using lactic acid. This tiny change acts like a shield, stopping the cancer cells from dying a natural death called "ferroptosis."

The good news? When researchers used a special antibody to block this shape-change, the shield fell apart. The cancer drugs started working again, and the tumors shrank! This exciting discovery could lead to much better treatments for liver cancer in the near future.